Combo Brachytherapy Improves Local Control in Cervical CancerCombo Brachytherapy Improves Local Control in Cervical Cancer
A combination of both interstitial and intracavitary brachytherapy for locally advanced cervical cancer improves local control. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 28, 2015 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Brachytherapy Boosts Survival in Inoperable Endometrial CancerBrachytherapy Boosts Survival in Inoperable Endometrial Cancer
Women with inoperable early-stage endometrial cancer survive longer if their treatment includes brachytherapy rather than external beam radiotherapy alone. Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 27, 2015 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Brachytherapy implants boost odds of halting prostate cancer
Prostate cancer patients treated with radioactive implants are twice as likely to find the disease has stabilised after five years, a study has found. (Source: the Mail online | Health)
Source: the Mail online | Health - April 27, 2015 Category: Consumer Health News Source Type: news
Prostate cancer patients who receive permanent radiotherapy implants twice as likely to be free of cancer after five years
Results from a randomised controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer-free five years later. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 27, 2015 Category: Science Source Type: news
Trial of radioactive implants offers improved prostate cancer survival
Treatment using permanently implanted radioactive ‘seeds’ doubles rates of five-year tumour-free survival compared with conventional high-dose radiotherapyA prostate cancer treatment using permanently implanted radioactive “seeds” doubles rates of five-year tumour-free survival compared with conventional high-dose radiotherapy, a study has found.Low-dose-rate prostate brachytherapy (LDR-PB) involves the insertion of tiny radioactive implants into the prostate gland.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 26, 2015 Category: Science Authors: Press Association Tags: Prostate cancer Cancer research Medical research Science Society Health World news Source Type: news
Permanent radiotherapy implants reduce risk of prostate cancer recurrence after 5 years
(European Society for Radiotherapy and Oncology (ESTRO)) Results from a randomized controlled trial to compare the use of permanent radioactive implants (brachytherapy) with dose-escalated external beam radiotherapy in patients with prostate cancer show that the men who received brachytherapy were twice as likely to be cancer-free five years later. The research will be presented at the 3rd ESTRO Forum in Barcelona, Spain, (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 26, 2015 Category: Cancer & Oncology Source Type: news
Brachytherapy improves survival for inoperable early stage endometrial cancer
Women who have early stage endometrial cancer and are inoperable tend to live longer if they have been treated with brachytherapy with or without external beam radiation, according to new research. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 26, 2015 Category: Science Source Type: news
Brachytherapy improves survival for inoperable early stage endometrial cancer
(European Society for Radiotherapy and Oncology (ESTRO)) Women who have early stage endometrial cancer and are inoperable tend to live longer if they have been treated with brachytherapy with or without external beam radiation, according to new research to be presented at the 3rd ESTRO Forum in Barcelona, Spain. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 25, 2015 Category: Cancer & Oncology Source Type: news
Combined brachytherapy techniques should be 'benchmark' for cervical cancer treatment
The first large international study to investigate the late side-effects of a combination of two forms of brachytherapy to treat cervical cancer has shown that the technique successfully delivers higher radiation doses to the tumor without an increase in treatment-related problems afterwards. New research suggests that the technique should be the 'benchmark' for treatment of the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - April 25, 2015 Category: Science Source Type: news
Combined brachytherapy techniques should be 'benchmark' for cervical cancer treatment
(European Society for Radiotherapy and Oncology (ESTRO)) The first large international study to investigate the late side-effects of a combination of two forms of brachytherapy to treat cervical cancer has shown that the technique successfully delivers higher radiation doses to the tumor without an increase in treatment-related problems afterwards. The presentation at the 3rd Forum of the European Society for Radiotherapy and Oncology (ESTRO) in Barcelona suggests that the technique should be the 'benchmark' for treatment of the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 24, 2015 Category: Cancer & Oncology Source Type: news
iCAD touts early results from Xoft study
At the upcoming American Brachytherapy Society meeting in Orlando, FL, computer-aided (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 7, 2015 Category: Radiology Source Type: news
China approves Elekta's Flexitron brachytherapy
Elekta has received clearance for its Flexitron brachytherapy platform from (more) (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 18, 2014 Category: Radiology Source Type: news
Elekta Flexitron brachytherapy treatment delivery available in China
China Food and Drug Administration (CFDA) approves cancer treatment system
BEIJING, Dec. 18, 2014 -- (Healthcare Sales & Marketing Network) -- Elekta (EKTA-B.ST) announces that the China Food and Drug Administration (CFDA) has approved Elekta's Flexitr... Devices, Oncology, RegulatoryElekta, Flexitron, brachytherapy, afterloading (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 18, 2014 Category: Pharmaceuticals Source Type: news
UCLA study finds over-treatment for prostate cancer patients with life expectancies of fewer than 10 years
National guidelines recommend that men with low- and intermediate-risk prostate cancer who have life expectancies of fewer than 10 years should not be treated with radiation or surgery, since they are unlikely to live long enough to benefit from treatment. Yet a new study by UCLA researchers found that more than half of such men are receiving these aggressive treatments putting them at risk for potentially debilitating side effects.
In the first study to rigorously address prostate cancer treatment trends by life expectancy in a large, nationally representative sample, UCLA researchers found that more than half of prostate...
Source: UCLA Newsroom: Health Sciences - December 6, 2014 Category: Universities & Medical Training Source Type: news
Prostate Brachytherapy Has Good Long-term OutcomesProstate Brachytherapy Has Good Long-term Outcomes
Dr Gerald Chodak reviews a new study reporting extremely favorable long-term outcomes with brachytherapy for prostate cancer, but as usual, there are important caveats. Medscape Urology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - October 17, 2014 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
